ERBB2 and breast carcinoma: The Human Epidermal Growth Factor Receptor 2 (HER2) oncogene is responsible for encoding a transmembrane tyrosine kinase which is over expressed in 20–25% of breast cancers and is associated with a worse prognosis [1,2].